Circulating angiogenic cell populations, vascular function, and arterial stiffness

Atherosclerosis

Volumn 220, Issue 1, 2012, Pages 145-150

  Cheng, Susan ^a,b   Wang, Na ^d   Larson, Martin G ^a,e   Palmisano, Joseph N ^d   Mitchell, Gary F ^c   Benjamin, Emelia J ^a,d,g   Vasan, Ramachandran S ^a,g   Levy, Daniel ^a,f   McCabe, Elizabeth L ^h   Vita, Joseph A ^g   Wang, Thomas J ^a,h   Shaw, Stanley Y ^h   Cohen, Kenneth S ^i,j   Hamburg, Naomi M ^a,g  

^a FRAMINGHAM HEART STUDY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CARDIOVASCULAR ENGINEERING INC   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e USA   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^j UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

more..

Author keywords

Angiogenesis; Endothelium; Epidemiology; Risk factors; Vascular function

Indexed keywords

ADULT; AGED; ANGIOGENESIS; ARTERIAL STIFFNESS; ARTERY BLOOD FLOW; ARTERY TONE; ARTICLE; CARDIOVASCULAR RISK; CELL POPULATION; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PRIORITY JOURNAL; PULSE WAVE; TONOMETRY; VASODILATATION;

AGED; ANTIGENS, CD34; BIOLOGICAL MARKERS; BONE MARROW CELLS; BRACHIAL ARTERY; CAROTID ARTERIES; COLONY-FORMING UNITS ASSAY; CROSS-SECTIONAL STUDIES; ELASTICITY; FEMALE; FLOW CYTOMETRY; HEMODYNAMICS; HUMANS; LINEAR MODELS; MALE; MANOMETRY; MASSACHUSETTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL ARTERIAL DISEASE; PHENOTYPE; PULSATILE FLOW; RISK ASSESSMENT; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASODILATION;

EID: 84155172489     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.10.015     Document Type: Article

References (36)

1. Sirker A.A., Astroulakis Z.M., Hill J.M. Vascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult. Clin Sci (Lond) 2009, 116:283-299.
2. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
3. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430-436.
4. Gulati R., Jevremovic D., Peterson T.E., et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 2003, 108:1520-1526.
5. Griese D.P., Ehsan A., Melo L.G., et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003, 108:2710-2715.
6. Werner N., Priller J., Laufs U., et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002, 22:1567-1572.
7. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7.
8. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
9. Shaw S.Y., Cheng S., Cupples L.A., et al. Genetic and clinical correlates of early-outgrowth colony-forming units. Circ Cardiovasc Genet 2011, 4:296-304.
10. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005, 111:2981-2987.
11. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
12. Fadini G.P., Maruyama S., Ozaki T., et al. Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. PLoS One 2010, 5:e11488.
13. Sibal L., Aldibbiat A., Agarwal S.C., et al. Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria. Diabetologia 2009, 52:1464-1473.
14. Subramaniyam V., Waller E.K., Murrow J.R., et al. Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease. Am Heart J 2009, 158:53-60. e51.
15. Tao J., Wang Y., Yang Z., Tu C., Xu M.G., Wang J.M. Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age. J Hum Hypertens 2006, 20:490-495.
16. Schlieper G., Hristov M., Brandenburg V., et al. Predictors of low circulating endothelial progenitor cell numbers in haemodialysis patients. Nephrol Dial Transplant 2008, 23:2611-2618.
17. Murphy C., Kanaganayagam G.S., Jiang B., et al. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol 2007, 27:936-942.
18. Kannel W.B., Feinleib M., McNamara P.M., Garrison R.J., Castelli W.P. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979, 110:281-290.
19. Duda D.G., Cohen K.S., Scadden D.T., Jain R.K. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007, 2:805-810.
20. Benjamin E.J., Larson M.G., Keyes M.J., et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 2004, 109:613-619.
21. Mitchell G.F., Parise H., Benjamin E.J., et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension 2004, 43:1239-1245.
22. Hamburg N.M., Keyes M.J., Larson M.G., et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008, 117:2467-2474.
23. Hamburg N.M., Benjamin E.J. Assessment of endothelial function using digital pulse amplitude tonometry. Trends Cardiovasc Med 2009, 19:6-11.
24. Mitchell G.F., Guo C.Y., Benjamin E.J., et al. Cross-sectional correlates of increased aortic stiffness in the community: the Framingham Heart Study. Circulation 2007, 115:2628-2636.
25. Werner N., Wassmann S., Ahlers P., et al. Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007, 102:565-571.
26. Boilson B.A., Kiernan T.J., Harbuzariu A., Nelson R.E., Lerman A., Simari R.D. Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction. Nat Clin Pract Cardiovasc Med 2008, 5:489-496.
27. Leone A.M., Valgimigli M., Giannico M.B., et al. From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Eur Heart J 2009, 30:890-899.
28. Wojakowski W., Kucia M., Kazmierski M., Ratajczak M.Z., Tendera M. Circulating progenitor cells in stable coronary heart disease and acute coronary syndromes: relevant reparatory mechanism?. Heart 2008, 94:27-33.
29. Sekiguchi H., Ii M., Losordo D.W. The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. J Cell Physiol 2009, 219:235-242.
30. Nogueras S., Merino A., Ojeda R., et al. Coupling of endothelial injury and repair: an analysis using an in vivo experimental model. Am J Physiol Heart Circ Physiol 2008, 294:H708-H713.
31. Guven H., Shepherd R.M., Bach R.G., Capoccia B.J., Link D.C. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 2006, 48:1579-1587.
32. Bielak L.F., Horenstein R.B., Ryan K.A., et al. P.A. Circulating CD34+ cell count is associated with extent of subclinical atherosclerosis in asymptomatic Amish men, independent of 10-year Framingham risk. Clin Med: Cardiol 2009, 3:53-60.
33. Cheng S., Cohen K.S., Shaw S.Y., et al. Association of colony-forming units with coronary artery and abdominal aortic calcification. Circulation 2010, 122:1176-1182.
34. Charakida M., Masi S., Luscher T.F., Kastelein J.J., Deanfield J.E. Assessment of atherosclerosis: the role of flow-mediated dilatation. Eur Heart J 2010, 31:2854-2861.
35. Cavalcante J.L., Lima J.A., Redheuil A., Al-Mallah M.H. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 2011, 57:1511-1522.
36. Hristov M., Erl W., Weber P.C. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003, 23:1185-1189.